Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Confidential contracting

Claes Buxfeldt joins NDA

He becomes its new HTA director

- PMLiVE

Caroline Benson wins IPA and Campaign Women of Tomorrow Award 2018

Judges says Benson runs an ‘ethical’ business with a strong ‘ethos’

- PMLiVE

The valuable brand

Creating value beyond the pill is both possible and increasingly necessary

- PMLiVE

Novo Nordisk’s semaglutide obesity trial hits the mark

The injection helped adults lose up to 13.8% of their body weight in a year

- PMLiVE

New data could put Roche’s Tecentriq first in squamous lung cancer

NSCLC patients on the drug saw a reduced risk of disease progression

- PMLiVE

Mundipharma adds breast cancer biosimilar to its portfolio with Celltrion deal

Will launch Herzuma in seven European countries including the UK and Germany

- PMLiVE

Parexel appoints CEO

Jamie Macdonald succeeds co-founder Josef von Rickenbach

Metrion Biosciences adds to its board

Dr Barry Kenny and Dr Andrew Southan join the company

The rise of real-world evidence

Demonstrating efficacy and value requires more than clinical trial data

- PMLiVE

IQVIA partners with Box

Will work on managing content for the life science industry

- PMLiVE

Lundbeck signs $1.1bn deal for Prexton and Parkinson’s drug

Foliglurax is currently in phase II testing for LID, muscle stiffness and ‘freezing’

- PMLiVE

EMA starts review of Xtandi in non-metastatic prostate cancer

The evaluation is based on positive results from the PROSPER trial

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links